| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2009PNAS..106.9791S |
| P356 | DOI | 10.1073/PNAS.0813106106 |
| P932 | PMC publication ID | 2687996 |
| P698 | PubMed publication ID | 19478057 |
| P5875 | ResearchGate publication ID | 26249252 |
| P50 | author | David I Watkins | Q66732113 |
| Thomas C. Friedrich | Q37367145 | ||
| Mauricio A Martins | Q56427698 | ||
| Matthew B Buechler | Q56427816 | ||
| P2093 | author name string | Nancy A Wilson | |
| Jonah B Sacha | |||
| Enrique J León | |||
| Nicholas J Maness | |||
| Juan P Giraldo-Vela | |||
| Chungwon Chung | |||
| Lyle T Wallace | |||
| Atsunobu Hiraoka | |||
| P2860 | cites work | Broad Specificity of Virus-Specific CD4+ T-Helper-Cell Responses in Resolved Hepatitis C Virus Infection | Q27472915 |
| Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia | Q28254584 | ||
| Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans | Q28345408 | ||
| Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes | Q29616210 | ||
| HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help | Q29620766 | ||
| Specificity and degeneracy of T cells | Q33199993 | ||
| Macrophages archive HIV-1 virions for dissemination in trans | Q33215934 | ||
| Virus-specific CD4+ and CD8+ cytotoxic T-cell responses and long-term T-cell memory in individuals vaccinated against polio | Q33780559 | ||
| Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques | Q33781916 | ||
| Protection by live, attenuated simian immunodeficiency virus against heterologous challenge. | Q33820014 | ||
| HIV preferentially infects HIV-specific CD4+ T cells | Q33958893 | ||
| Cellular immune responses to HIV. | Q34223069 | ||
| Increased macrophage infection upon subcutaneous inoculation of rhesus macaques with simian immunodeficiency virus-loaded dendritic cells or T cells but not with cell-free virus | Q34347386 | ||
| Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity | Q71608561 | ||
| Characterization of CD4(+) CTLs ex vivo | Q74145676 | ||
| Presence of HIV-1 Gag-specific IFN-gamma+IL-2+ and CD28+IL-2+ CD4 T cell responses is associated with nonprogression in HIV-1 infection | Q78551235 | ||
| Cutting edge: MHC class II-restricted killing in vivo during viral infection | Q81235500 | ||
| Preferential infection shortens the life span of human immunodeficiency virus-specific CD4+ T cells in vivo | Q34717597 | ||
| Subdominant CD8+ T-cell responses are involved in durable control of AIDS virus replication | Q35785115 | ||
| Helping the CD8(+) T-cell response | Q35852274 | ||
| Gag-specific CD8+ T lymphocytes recognize infected cells before AIDS-virus integration and viral protein expression | Q35904453 | ||
| Expansion and contraction of HIV-specific CD4 T cells with short bursts of viremia, but physical loss of the majority of these cells with sustained viral replication | Q36149329 | ||
| Induction of a virus-specific effector-memory CD4+ T cell response by attenuated SIV infection | Q36228123 | ||
| Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins. | Q36228567 | ||
| Pol-specific CD8+ T cells recognize simian immunodeficiency virus-infected cells prior to Nef-mediated major histocompatibility complex class I downregulation | Q36315000 | ||
| HIV-1 Vpr enhances viral burden by facilitating infection of tissue macrophages but not nondividing CD4+ T cells | Q36370102 | ||
| West Nile virus-specific CD4 T cells exhibit direct antiviral cytokine secretion and cytotoxicity and are sufficient for antiviral protection | Q36418554 | ||
| The major histocompatibility complex class II alleles Mamu-DRB1*1003 and -DRB1*0306 are enriched in a cohort of simian immunodeficiency virus-infected rhesus macaque elite controllers | Q36424504 | ||
| Immune escape precedes breakthrough human immunodeficiency virus type 1 viremia and broadening of the cytotoxic T-lymphocyte response in an HLA-B27-positive long-term-nonprogressing child | Q36684112 | ||
| Beyond help: direct effector functions of human immunodeficiency virus type 1-specific CD4(+) T cells. | Q36684398 | ||
| Differential antigen presentation kinetics of CD8+ T-cell epitopes derived from the same viral protein | Q36898739 | ||
| Reduced protection from simian immunodeficiency virus SIVmac251 infection afforded by memory CD8+ T cells induced by vaccination during CD4+ T-cell deficiency | Q36898836 | ||
| Macaques vaccinated with live-attenuated SIV control replication of heterologous virus | Q36946545 | ||
| Vaccine-induced cellular responses control simian immunodeficiency virus replication after heterologous challenge | Q37232824 | ||
| Enhanced SIV replication and accelerated progression to AIDS in macaques primed to mount a CD4 T cell response to the SIV envelope protein | Q37511699 | ||
| Inhibition of endogenous MHC class II-restricted antigen presentation by tacrolimus (FK506) via FKBP51. | Q39093643 | ||
| Preservation of a critical epitope core region is associated with the high degree of flaviviral cross-reactivity exhibited by a dengue-specific CD4+ T cell clone | Q39267118 | ||
| Multiple effector functions mediated by human immunodeficiency virus-specific CD4(+) T-cell clones | Q39604412 | ||
| Human monocytes differentiate into macrophages under the influence of human KPB-M15 conditioned medium | Q40417814 | ||
| Endogenous MHC class II processing of a viral nuclear antigen after autophagy. | Q40481959 | ||
| Flexibility in MHC and TCR recognition: degenerate specificity at the T cell level in the recognition of promiscuous Th epitopes exhibiting no primary sequence homology | Q40804908 | ||
| The arrival of HLA class II tetramers | Q40857969 | ||
| Macrophage-derived simian immunodeficiency virus exhibits enhanced infectivity by comparison with T-cell-derived virus | Q41914053 | ||
| Analysis of host-virus interactions in AIDS with anti-gp120 T cell clones: effect of HIV sequence variation and a mechanism for CD4+ cell depletion | Q42818707 | ||
| Cyclosporin A and tacrolimus, but not rapamycin, inhibit MHC-restricted antigen presentation pathways in dendritic cells | Q45229049 | ||
| Strong selection of virus-specific cytotoxic CD4+ T-cell clones during primary human cytomegalovirus infection. | Q45414545 | ||
| Rapid MHC-II antigen presentation of HIV type 1 by human dendritic cells. | Q53543523 | ||
| HIV-1-specific CTLs effectively suppress replication of HIV-1 in HIV-1-infected macrophages. | Q53570851 | ||
| Dendritic cells and HIV-specific CD4+ T cells: HIV antigen presentation, T-cell activation, and viral transfer | Q56795504 | ||
| Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia | Q57075698 | ||
| T cells can present antigens such as HIV gp120 targeted to their own surface molecules | Q57160468 | ||
| P433 | issue | 24 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | macrophage | Q184204 |
| P1104 | number of pages | 6 | |
| P304 | page(s) | 9791-9796 | |
| P577 | publication date | 2009-05-28 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Gag- and Nef-specific CD4+ T cells recognize and inhibit SIV replication in infected macrophages early after infection | |
| P478 | volume | 106 |
| Q28742853 | A DNA vaccine encoding multiple HIV CD4 epitopes elicits vigorous polyfunctional, long-lived CD4+ and CD8+ T cell responses |
| Q38289113 | A critical analysis of the cynomolgus macaque, Macaca fascicularis, as a model to test HIV-1/SIV vaccine efficacy |
| Q36880380 | A novel SIV gag-specific CD4(+)T-cell clone suppresses SIVmac239 replication in CD4(+)T cells revealing the interplay between antiviral effector cells and their infected targets |
| Q28751663 | A vaccine encoding conserved promiscuous HIV CD4 epitopes induces broad T cell responses in mice transgenic to multiple common HLA class II molecules |
| Q37073319 | Biphasic CD8+ T-Cell Defense in Simian Immunodeficiency Virus Control by Acute-Phase Passive Neutralizing Antibody Immunization. |
| Q34428561 | Broad and cross-clade CD4+ T-cell responses elicited by a DNA vaccine encoding highly conserved and promiscuous HIV-1 M-group consensus peptides |
| Q56772813 | Bupivacaine enhances the magnitude and longevity of HIV-specific immune response after immunization with a CD4 epitope-based DNA vaccine |
| Q37123579 | CD4+ T cells support production of simian immunodeficiency virus Env antibodies that enforce CD4-dependent entry and shape tropism in vivo |
| Q36394661 | CD8+ and CD4+ cytotoxic T cell escape mutations precede breakthrough SIVmac239 viremia in an elite controller |
| Q36450329 | Co-administration of plasmid-encoded granulocyte-macrophage colony-stimulating factor increases human immunodeficiency virus-1 DNA vaccine-induced polyfunctional CD4+ T-cell responses. |
| Q41916926 | Comparative analysis of the capacity of elite suppressor CD4+ and CD8+ T cells to inhibit HIV-1 replication in monocyte-derived macrophages |
| Q28487823 | Consensus HIV-1 FSU-A integrase gene variants electroporated into mice induce polyfunctional antigen-specific CD4+ and CD8+ T cells |
| Q37812127 | Cytolytic CD4+T cells in viral immunity |
| Q37597931 | Cytotoxic CD4 T Cells-Friend or Foe during Viral Infection? |
| Q21296742 | Cytotoxic CD4 T cells in antiviral immunity |
| Q37628515 | Dendritic Cell Targeting Effectively Boosts T Cell Responses Elicited by an HIV Multiepitope DNA Vaccine |
| Q35484743 | Depletion of CD4⁺ T cells abrogates post-peak decline of viremia in SIV-infected rhesus macaques |
| Q38619108 | Development of a Sendai virus vector-based AIDS vaccine inducing T cell responses |
| Q36284619 | Early HIV RNA decay during raltegravir-containing regimens exhibits two distinct subphases (1a and 1b). |
| Q36607025 | Early antigen presentation of protective HIV-1 KF11Gag and KK10Gag epitopes from incoming viral particles facilitates rapid recognition of infected cells by specific CD8+ T cells |
| Q43942291 | Enhanced expression of HIV and SIV vaccine antigens in the structural gene region of live attenuated rubella viral vectors and their incorporation into virions |
| Q37667998 | Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4+ T Cells |
| Q26850379 | Gastrointestinal tract and the mucosal macrophage reservoir in HIV infection |
| Q33535905 | HIV controller CD4+ T cells respond to minimal amounts of Gag antigen due to high TCR avidity |
| Q41762711 | HIV controllers maintain a population of highly efficient Th1 effector cells in contrast to patients treated in the long term. |
| Q37921949 | HIV controllers: a multifactorial phenotype of spontaneous viral suppression |
| Q26825087 | HIV-1 envelope-receptor interactions required for macrophage infection and implications for current HIV-1 cure strategies |
| Q41937295 | HIV-specific cytolytic CD4 T cell responses during acute HIV infection predict disease outcome |
| Q35753766 | HLA Class-II Associated HIV Polymorphisms Predict Escape from CD4+ T Cell Responses. |
| Q37051248 | HLA/KIR restraint of HIV: surviving the fittest |
| Q34575451 | Immune mechanisms of HIV control |
| Q28477088 | Implications of CTL-mediated killing of HIV-infected cells during the non-productive stage of infection |
| Q42130441 | Innate and Adaptive Immunity in Long-Term Non-Progression in HIV Disease |
| Q52719601 | Limited immune surveillance in lymphoid tissue by cytolytic CD4+ T cells during health and HIV disease. |
| Q42284964 | Live attenuated rubella viral vectors stably express HIV and SIV vaccine antigens while reaching high titers |
| Q35487807 | Long-term control of simian immunodeficiency virus (SIV) in cynomolgus macaques not associated with efficient SIV-specific CD8+ T-cell responses |
| Q36385484 | Lymph node T cell responses predict the efficacy of live attenuated SIV vaccines |
| Q45875626 | Magnetic nanoparticles enhance adenovirus transduction in vitro and in vivo |
| Q28247202 | Magnetically enhanced nucleic acid delivery. Ten years of magnetofection-progress and prospects |
| Q35665916 | Mucosal and peripheral Lin- HLA-DR+ CD11c/123- CD13+ CD14- mononuclear cells are preferentially infected during acute simian immunodeficiency virus infection |
| Q64074435 | Mucosal and systemic SIV-specific cytotoxic CD4+ T cell hierarchy in protection following intranasal/intramuscular recombinant pox-viral vaccination of pigtail macaques |
| Q36140156 | NK and CD4+ T cell cooperative immune responses correlate with control of disease in a macaque simian immunodeficiency virus infection model |
| Q36086379 | Nef Is Dispensable for Resistance of Simian Immunodeficiency Virus-Infected Macrophages to CD8+ T Cell Killing |
| Q34650866 | Pathogenesis and treatment of HIV infection: the cellular, the immune system and the neuroendocrine systems perspective |
| Q36754331 | Polyinosinic-polycytidylic acid is the most effective TLR adjuvant for SIV Gag protein-induced T cell responses in nonhuman primates |
| Q50281273 | Propionibacterium acnes Enhances the Immunogenicity of HIVBr18 Human Immunodeficiency Virus-1 Vaccine. |
| Q34574409 | Rapid SIV Env-specific mucosal and serum antibody induction augments cellular immunity in protecting immunized, elite-controller macaques against high dose heterologous SIV challenge |
| Q35077809 | Reduction of CD4+ T cells in vivo does not affect virus load in macaque elite controllers |
| Q40633369 | Short Communication: HIV Controller T Cells Effectively Inhibit Viral Replication in Alveolar Macrophages |
| Q34477154 | Simian immunodeficiency virus-specific CD4+ T cells from successful vaccinees target the SIV Gag capsid |
| Q37687859 | Synchronous infection of SIV and HIV in vitro for virology, immunology and vaccine-related studies |
| Q33826671 | T-cell correlates of vaccine efficacy after a heterologous simian immunodeficiency virus challenge |
| Q47556867 | T-cell responses to KSHV infection: a systematic approach. |
| Q36246121 | Technical advance: liposomal alendronate depletes monocytes and macrophages in the nonhuman primate model of human disease |
| Q54253587 | The anti-caspase inhibitor Q-VD-OPH prevents AIDS disease progression in SIV-infected rhesus macaques. |
| Q52593219 | The dynamics of SIV 2-LTR Circles in the Presence and Absence of CD8+ Cells. |
| Q35868086 | The majority of freshly sorted simian immunodeficiency virus (SIV)-specific CD8(+) T cells cannot suppress viral replication in SIV-infected macrophages |
| Q40537002 | The primary immune response to Vaccinia virus vaccination includes cells with a distinct cytotoxic effector CD4 T-cell phenotype. |
| Q34008900 | Transduction of SIV-specific TCR genes into rhesus macaque CD8+ T cells conveys the ability to suppress SIV replication |
| Q27315009 | Vaccination against endogenous retrotransposable element consensus sequences does not protect rhesus macaques from SIVsmE660 infection and replication |
| Q27332360 | Vaccination against heterologous R5 clade C SHIV: prevention of infection and correlates of protection |
| Q38082905 | Will it be possible to live without antiretroviral therapy? |
Search more.